Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 37 Records) |
| Query Trace: Diabetes Mellitus and CYP2C19[original query] |
|---|
| Antiplatelet resistance in outpatients with monitored adherence. Platelets 2014 25 (7): 532-8. Walter Philipp N, Tsakiris Dimitrios A, Romanens Michel, Arnet Isabelle, Hersberger Kurt |
| Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy: a retrospective longitudinal study in Japanese patients with type 2 diabetes. Pharmacogenetics and genomics 2013 Dec 23 (12): 717-20. Kajiwara Ayami, Saruwatari Junji, Kita Ayana, Kamihashi Ryoko, Miyagawa Haruna, Sakata Misaki, Noai Madoka, Oniki Kentaro, Yoshida Akira, Jinnouchi Hideaki, Nakagawa Kazu |
| Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary intervention. PloS one 2014 9 (7): e102701. Siller-Matula Jolanta M, Lang Irene M, Neunteufl Thomas, Kozinski Marek, Maurer Gerald, Linkowska Katarzyna, Grzybowski Tomasz, Kubica Jacek, Jilma Ber |
| Impact of CYP2C19 polymorphism on clinical outcome following coronary stenting is more important in non-diabetic than diabetic patients. Thrombosis research 2014 Jul 134 (1): 72-7. Mizobe Michio, Hokimoto Seiji, Akasaka Tomonori, Arima Yuichiro, Kaikita Koichi, Morita Kazunori, Miyazaki Hiroko, Oniki Kentaro, Nakagawa Kazuko, Ogawa His |
| CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention. Coronary artery disease 2014 Aug 25 (5): 412-20. Liu Tao, Yin Tao, Li Yan, Song Li-Qiang, Yu Jin, Si Rui, Zhang Ying-Mei, He Yuan, Guo Wen-Yi, Wang Hai-Cha |
| Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016 Aug . Yi Xingyang, Zhou Qiang, Wang Chun, Lin Jing, Cheng Wen, Chi Lif |
| Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial. Thrombosis and haemostasis 2016 07 116 (1): 69-77. Carreras Edward T, Hochholzer Willibald, Frelinger Andrew L, Nordio Francesco, O'Donoghue Michelle L, Wiviott Stephen D, Angiolillo Dominick J, Michelson Alan D, Sabatine Marc S, Mega Jessica |
| Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. Journal of atherosclerosis and thrombosis 2016 Mar . Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Qiang, Wang Chun, Cheng Wen, Chi Lif |
| Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite. European journal of clinical pharmacology 2017 Sep . Danielak Dorota, Kara?niewicz-?ada Marta, Komosa Anna, Burchardt Pawe?, Lesiak Maciej, Kruszyna ?ukasz, Graczyk-Szuster Agnieszka, G?ówka Francisz |
| CYP2C19 activity and cardiovascular risk factors in patients with an acute coronary syndrome. Medicina clinica 2017 May . Martínez-Quintana Efrén, Rodríguez-González Fayna, Medina-Gil José María, Garay-Sánchez Paloma, Tugores Anton |
| Baseline platelet parameters for predicting early platelet response and clinical outcomes in patients with non-cardioembolic ischemic stroke treated with clopidogrel. Oncotarget 2017 Nov 8 (55): 93771-93784. Li Wenxian, Xie Xiaomei, Wei Di, Zhang Shijun, Wu Yuanling, Fu Xuejun, Jing Zhen, Lu Weibiao, Lai Xinqiang, Huang Li' |
| Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
| Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype? European journal of clinical pharmacology 2018 Aug . Chouchene Saoussen, Dabboubi Rym, Raddaoui Haythem, Abroug Hela, Ben Hamda Khaldoun, Hadj Fredj Sondess, Abderrazak Fatma, Gaaloul Mayssa, Rezek Marwa, Neffeti Fadoua, Hellara Ilhem, Sassi Mouna, Khefacha Linda, Sriha Asma, Nouira Semir, Najjar Mohamed Fadhel, Maatouk Faouzi, Messaoud Taieb, Hassine Mohs |
| CYP2C19 or CYP3A5 Genotyping Does Not Predict Clinical Response to Clopidogrel. Journal of clinical pharmacology 2018 5 58 (10): 1274-1283. Rodríguez-González Fayna, Martínez-Quintana Efren, Saavedra Pedro, Medina-Gil José M, Riaño Marta, Garay-Sánchez Paloma, Tugores Anton |
| Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors. American journal of therapeutics 0 25 (2): e202-e212. Tomek Aleš, Mat?oška Václav, Frýdmanová Alena, Magerová Hana, Šrámek Martin, Paulasova-Schwabová Jaroslava, R?ži?ková Tereza, Janský Petr, Šarbochová Ivana, Hada?ová Ivana, Kaplan Vojt?ch, Lacinová Zuzana, Táborský Lud?k, Serebruany Vict |
| Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy. Drug metabolism and personalized therapy 2018 Feb . Hernandez-Suarez Dagmar F, Núñez-Medina Hector, Scott Stuart A, Lopez-Candales Angel, Wiley Jose M, Garcia Mario J, Melin Kyle, Nieves-Borrero Karid, Rodriguez-Ruiz Christina, Marshall Lorraine, Duconge Jor |
| Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring. Journal of gastroenterology and hepatology 2019 7 34 (12): 2112-2117. Deguchi Hisato, Yamazaki Hajime, Yamamoto Yosuke, Fukuhara Shunic |
| Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel. Circulation. Cardiovascular interventions 2019 May 12 (5): e007019. Xu Ke, Ye Sen, Zhang Shuhua, Yang Mingwen, Zhu Tiantian, Kong Deyu, Chen Jun, Xu Lei, Li Jimin, Zhu Hui, Wang Fei, Yang Lu, Zhang Jing, Fan Yuansheng, Ying Lianghong, Hu Xianqing, Zhang Xiaofeng, Chan Noel C, Li Chunji |
| Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics. Cardiovascular drugs and therapy 2020 7 35 (3): 549-559. Morales-Rosado Joel A, Goel Kashish, Zhang Lingxin, Åkerblom Axel, Baheti Saurabh, Black John L, Eriksson Niclas, Wallentin Lars, James Stefan, Storey Robert F, Goodman Shaun G, Jenkins Gregory D, Eckloff Bruce W, Bielinski Suzette J, Sicotte Hugues, Johnson Stephen, Roger Veronique L, Wang Liewei, Weinshilboum Richard, Klee Eric W, Rihal Charanjit S, Pereira Naveen |
| Should CYP2C19 Genotyping Be Recommended as a Straight Forward Approach to Optimize Clopidogrel Utilization in Patients with Ischemic Stroke Complicated by Type 2 Diabetes Mellitus? Pharmacogenomics and personalized medicine 2020 13 645-653. Sun Jialin, Leng Ping, Sun Chen, Xu Wen, Zhao Zhenhuan, Li Xiao, Zhang Xiaolei, Li Ji |
| The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention. European journal of clinical pharmacology 2021 6 77 (11): 1679-1686. Wang Tingting, Li Hongjian, Wang Fengxia, Sun Li, Yu Luh |
| CLINICAL AND GENETIC FACTORS OF CARDIOVASCULAR EVENTS DEVELOPMENT AFTER PERCUTANEOUS CORONARY INTERVENTION. Georgian medical news 2021 5 (312): 52-56. Taizhanova D, Kalimbetova A, Toleuova A, Bodaubay R, Turmukhambetova |
| Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome. Journal of clinical pharmacology 2021 12 62 (6): 783-791. Santana-Mateos Marta, Medina-Gil José M, Saavedra-Santana Pedro, Martínez-Quintana Efrén, Rodríguez-González Fayna, Tugores Anton |
| CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: a matched case-control study. Drug metabolism and personalized therapy 2021 12 37 (2): 155-161. Osama Sara, Wirth Francesca, Zahra Graziella, Barbara Christopher, Xuereb Robert G, Camilleri Liberato, Azzopardi Lilian |
| The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics. Genes 2021 11 12 (11): . Austin-Zimmerman Isabelle, Wronska Marta, Wang Baihan, Irizar Haritz, Thygesen Johan H, Bhat Anjali, Denaxas Spiros, Fatemifar Ghazaleh, Finan Chris, Harju-Seppänen Jasmine, Giannakopoulou Olga, Kuchenbaecker Karoline, Zartaloudi Eirini, McQuillin Andrew, Bramon Elvi |
| Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation. Clinical pharmacology and therapeutics 2022 4 112 (1): 146-155. Thomas Cameron D, Franchi Francesco, Keeley Ellen C, Rossi Joseph S, Winget Marshall, David Anderson R, Dempsey Alyssa L, Gong Yan, Gower Megan N, Kerensky Richard A, Kulick Natasha, Malave Jean G, McDonough Caitrin W, Mulrenin Ian R, Starostik Petr, Beitelshees Amber L, Johnson Julie A, Stouffer George A, Winterstein Almut G, Angiolillo Dominick J, Lee Craig R, Cavallari Larisa |
| CYP2C19 Loss-of-Function Variants Associated with Long-term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population. Clinical pharmacology and therapeutics 2023 8 . Peng Wu, Ziqing Liu, Zijian Tian, Benrui Wu, Jian Shao, Qian Li, Zhaoxu Geng, Ying Pan, Ke Lu, Qiang Wang, Tao Xu, Kaixin Zh |
| Association of CYP2C19 Polymorphic Markers with Cardiovascular Disease Risk Factors in Gas Industry Workers Undergoing Periodic Medical Examinations. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2023 2 . Sychev Dmitry Alekseevich, Polyakova Olga Alexandrovna, Sozaeva Zhannet Alimovna, Mirzaev Karin Badavievich, Ostroumova Olga Dmitriev |
| CYP2C19 Poor Metabolizer Status and High System Inflammation Response Index are Independent Risk Factors for Premature Myocardial Infarction: A Hospital-Based Retrospective Study. International journal of general medicine 2024 11 17 4959-4969. Wendao Han, Nating Xiong, Renkai Zhong, Zhongyi P |
| CYP2C19 loss-of-function variants are independent risk factors for premature cerebral infarction: a hospital based retrospective study. BMC cardiovascular disorders 2024 10 24 (1): 602. Yuliang Shi, Yuxian Yang, Miaoling Feng, Heming |
- Page last reviewed:Feb 1, 2024
- Content source: